Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2015 · 10-Q
Revenue$5.17B$5.17B+2.2% vs Q2 2014 Net Income$784.00M$784.00M+68.2% vs Q2 2014 EPS Diluted$0.52$0.52+73.3% vs Q2 2014 Gross Profit$2,801,000,000+6.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$941,000,000+4.6% Free Cash Flowderived$725,000,000+12.9% Margins · derivedGross margin54.2%+2.1 pt vs Q2 2014
Operating margin14.1%+0.7 pt vs Q2 2014
Net margin15.2%+5.9 pt vs Q2 2014
ended Jun 30, 2015 · filed Aug 4, 2015 · 35 d after period end